Skinsearch of Rochester Inc

Rochester, New York 146232

1 studies enrolling now · 44 studies all time

What they study most

Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Alopecia Areata, Alopecia Areata (AA), Atoptic Dermatitis, Chronic Plaque Psoriasis, Chronic Pruritus, Cutaneous Neurofibroma, Glabellar Lines, Hidradenitis Suppurativa, Hyperhidrosis

Studies at this site

• A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows — Recruiting now
• Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults — Completed
• Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp — Completed
• A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) — Running, not enrolling
• Phase 2b Study of EVO756 in Adults With Atopic Dermatitis — Running, not enrolling
• NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) — Completed
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants — Completed
• Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). — Running, not enrolling
• A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp — Stopped early
• A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp — Completed
• Evaluation of the Dermal Cooling System for Treatment of Common Skin Conditions — Completed
• Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp — Completed
• MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL) — Completed
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis — Completed
• Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata — Completed
• A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis — Completed
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis — Completed
• MT10109L in the Treatment of Glabellar Lines — Completed
• CellFX System for the Treatment of Cutaneous Non-Genital Warts — Completed
• MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines — Completed
• NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) — Completed
• Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo — Completed
• VPD-737 for Treatment of Chronic Pruritus — Completed
• Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis — Completed
• Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
• A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
• A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
• A Phase II Study in Patients With Alopecia Areata — Completed
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp — Completed
• Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis — Stopped early
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) — Completed
• Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis — Completed
• Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis — Completed
• A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis — Completed
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients — Completed
• A Study of DER 45-EV Gel to Treat Rosacea — Completed
• A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis — Completed
• Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis — Completed
• Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails — Stopped early
• Clinical Trial To Evaluate ANT-1207 In Subjects With Acne — Completed
• The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed
• A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris — Completed